Tan­za­ni­ans vie for grant

East African Business Week - - HEALTH -

DAR ES SALAAM, TAN­ZA­NIA--TAN­ZA­NIAN sci­en­tists are among re­searchers across Sub-sa­hara Africa, who stand to win £100,000 (some $168,000) from a sci­ence-led global health­care com­pany en­gaged in re­search and devel­op­ment of Phar­ma­ceu­ti­cals, Vac­cines and Con­sumer Health­care in GSK’S Africa Non-com­mu­ni­ca­ble Dis­ease (NCD) Open Lab re­search fund­ing writes TI­MOTHY KITUNDU

Launched in 2014, The Africa NCD Open Lab is part of a se­ries of in­vest­ments GSK is mak­ing across sub-sa­ha­ran Africa. Through the pro­gram, GSK aims to work in part­ner­ship with African re­searchers and aca­demic groups to con­duct re­search into NCDS such as can­cer, di­a­betes, car­dio­vas­cu­lar dis­ease and chronic res­pi­ra­tory diseases.

Ac­cord­ing to a state­ment from GSK to me­dia houses last week, the third call for re­search pro­posal to ad­dress these grow­ing chal­lenges is open from Novem­ber 7th, 2016 un­til Jan­uary 12th 2017 and suc­cess­ful ap­pli­cants will be awarded £100,000 for up to two years, along with sci­en­tific sup­port from GSK.

It is hoped that the vi­tal re­search will im­prove the un­der­stand­ing of NCDS, and in­form best prac­tice, pre­ven­tion and treat­ment strate­gies.

“I en­cour­age sci­en­tists who are in­ter­ested to visit our web­site, http://www.gsk. com/en-gb/re­search/open-in­no­va­tion/ africa-ncd-open-lab where in­for­ma­tion on sub­mit­ting the pro­posal can be found,” Beno Mbeya, the GSK Med­i­cal Ad­vi­sor in Tan­za­nia said last week.

Sta­tis­tics in­di­cate that by 2014, NCDS ac­counted for nearly a third or 32% of to­tal deaths in Tan­za­nia, while across the country, the prob­a­bil­ity of dy­ing at the ages of be­tween 30 and 70 years from an NCD is 16%.

Mbeya said whilst huge progress has been made in re­cent years to un­der­stand and com­bat in­fec­tious diseases, more work needs to be done to tackle the grow­ing health con­cern pre­sented by NCDS in Tan­za­nia and across Sub-sa­ha­ran Africa and that when an is­sue is bet­ter un­der­stood it can be more ef­fec­tively tack­led.

Mbeya said by col­lab­o­rat­ing with GSK’S re­search net­work across Africa through the Open Lab pro­gram, Tan­za­nian sci­en­tists can work to vastly im­prove the un­der­stand­ing of NCDS in Tan­za­nia and be­yond.

Newspapers in English

Newspapers from Burundi

© PressReader. All rights reserved.